| |
CAMBRIDGE, MA — April 25, 2005
Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA), a biotechnology
company developing drugs based on its proprietary sugar sequencing technology,
announced today that Alan Crane, Chairman and Chief Executive Officer,
will present at the Deutsche Bank Securities 30th Annual Health Care
Conference on Monday, May 2, 2005 at 2:00 pm EDT at the Hyatt Regency
Hotel in Baltimore, MD. A live webcast of the presentation will be available
on the “Investors” section of the Company’s website
located at www.momentapharma.com. A replay of the presentation will
be posted on the Momenta website approximately thirty minutes after
the event and will be available through May 9, 2005.
About Momenta:
Momenta Pharmaceuticals, Inc. is a biotechnology company specializing
in the detailed structural analysis and design of complex sugars for
the development of improved versions of existing drugs, the development
of novel drugs and the discovery of new biological processes. Momenta
is also utilizing its ability to sequence sugars to create technology-enabled
generic versions of sugar-based and biologic drug products. The Company’s
most advanced product candidate is M-Enoxaparin, a technology-enabled
generic version of Lovenox®. Based on its understanding of complex
sugars, Momenta has created a diversified pipeline of near-term product
opportunities, novel development products and discovery candidates.
Momenta was founded in 2001 and is headquartered in Cambridge, MA.
To receive additional information about Momenta,
please visit our website at www.momentapharma.com, which does not form
a part of this press release.
Our logo, trademarks, and service marks are the property
of Momenta Pharmaceuticals, Inc. All other trade names, trademarks,
or service marks are property of their respective owners and are not
the property of Momenta Pharmaceuticals, Inc.
Contact:
Michael A. Lawless
Momenta Pharmaceuticals, Inc.
617-395-5189
|
|
Press
Contact
press@momentapharma.com
Company
Fact Sheet
Technology
Fact Sheet
Regulatory
Fact Sheet
|
